| Product Name | MF | CAS | Details |
|---|
| Azilsartan Impurity I | C24H18N4O5 | 1403474-78-1 | Details |
| Azilsartan Impurity 52 | C27H25N3O6 | 139481-38-2 | Details |
| Azilsartan Impurity I | C23H17N3O3 | 139481-33-7 | Details |
| Azilsartan Impurity N | C22H17N3O4 | 2244031-86-3 | Details |
| (4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | C12H14ClN3O2 | 1146629-75-5 | Details |
| bis(((R)-3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl) phenyl)-2-oxooxazolidin-5-yl)methyl) hydrogen phosphate | C34H29F2N12O8P | 1256966-02-5 | Details |
| Folic Acid EP Impurity F | C7H6ClN5O | 1391194-56-1 | Details |
| Dolutegravir Impurity 11 | C21H21F2N3O5 | 2227442-13-7 | Details |
| Azilsartan Impurity H | C23H20N4O4 | 1499167-72-4 | Details |
| N-((S)-10-formyl-5,6,7,8-tetrahydro-pteroyl)-L-glutamic acid | C20H23N7O7 | 74644-66-9 | Details |
| trans-Bilastine N-Oxide | C28H37N3O4 | 1934257-94-9 | Details |
| Azilsartan | C25H20N4O5 | 147403-03-0 | Details |
| Azilsartan Impurity C | C24H22N4O4 | 1397836-49-5 | Details |
| Azilsartan Impurity 45 | C22H19N3O2 | 136304-78-4 | Details |
| (R)-3-(4-(6-(1H-tetrazol-5-yl)pyridin-3-yl)-3-fluorophenyl)-5- (hydroxymethyl)oxazolidin-2-one | C16H13FN6O3 | 1771765-84-4 | Details |
| 2-Oxa-8-azaspiro[4.5]decan-4-amine, 3-methyl-, hydrochloride (1:2), (3S,4S)- | C9H19ClN2O | 2055761-19-6 | Details |
| Dolutegravir Impurity 16 | C20H19F2N3O5 | 1357289-37-2 | Details |
| NA | 16963392-11-6 | Details |
| Rocuronium Bromide EP Impurity C | C30H51BrN2O3 | 119302-86-2 | Details |
| Iguratimod Impurity | C16H19ClN2O5S | 149436-41-9 | Details |
| Azilsartan Impurity O | C23H19N3O4 | 2171316-29-1 | Details |
| Azilsartan Impurity K | C23H16N4O5 | 1442400-68-1 | Details |
| Aprepitant EP Impurity C | C29H25F7N4O3 | 2348441-63-2 | Details |
| Folic Acid EP Impurity H | C31H31N9O10 | 2366274-27-1 | Details |
| Ruxolitinib Impurity 17 | C18H21N5O2 | 2950130-23-9 | Details |
| Calcitriol EP Impurity A | C27H44O3 | 73837-24-8 | Details |
| Iguratimod Impurity | C16H16N2O6S | 149457-03-4 | Details |
| Dolutegravir Impurity 6 | C20H19F2N3O5 | 1357289-29-2 | Details |
| (R)-(3-(4-(6-(1H-tetrazol-5-yl)pyridin-3-yl)-3-fluorophenyl)-2- oxooxazolidin-5-yl)methyl dihydrogen phosphate | C16H14FN6O6P | 1239662-47-5 | Details |
| Vecuronium Bromide Impurity 4 | C31H52N2O3 | 13522-24-2 | Details |
| Methyl 2-(((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)amino)-3-nitrobenzoate | C22H17N3O4 | 139481-28-0 | Details |
| Rocuronium Bromide EP Impurity B | C34H55BrN2O5 | 122483-73-2 | Details |
| (5R)-3-[4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-5-[(phosphonooxy)methyl]-2-oxazolidinone | C37H34F2N14O11P2 | 1256966-04-7 | Details |
| Iguratimod Impurity | C18H16N2O6S | 123662-92-0 | Details |
| Azilsartan Impurity 3 | C29H25N3O7 | 1696392-12-7 | Details |
| Dolutegravir Impurity 3 | C20H19F2N3O5 | 1973402-05-9 | Details |
| Tedizolid Ring Open Impurity | C16H18FN6O5P | 1239662-49-7 | Details |
| Dolutegravir Impurity 9 | C20H20FN3O5 | 1863916-88-4 | Details |
| Trans-Haloperidol N-Oxide | C21H23ClFNO3 | 150214-93-0 | Details |
| (R)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide | C18H20ClN3O4S | 721401-53-2 | Details |
| Azilsartan Impurity M | C24H19N3O3 | 632322-61-3 | Details |
| Dolutegravir (S,R)-Isomer | C20H19F2N3O5 | 1309560-49-3 | Details |
| Iguratimod Impurity | C18H16N2O6S | 1179354-65-4 | Details |
| Dolutegravir Impurity 11 | C20H21N3O5 | 2244161-71-3 | Details |
| cis-Bilastine N-Oxide | C28H37N3O4 | 1934257-95-0 | Details |
| 3-cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propanenitrile | C17H26BN3O2 | 1153949-38-2 | Details |
| cis-Haloperidol N-Oxide | C21H23ClFNO3 | 150214-94-1 | Details |
| Rocuronium Bromide EP Impurity D | C32H53BrN2O4 | 1190105-63-5 | Details |
| Iguratimod Impurity | C16H14N2O5S | 123663-48-9 | Details |
| Azilsartan Impurity D | C22H18N4O4 | 1821386-21-3 | Details |
| Dolutegravir Impurity 8 | C20H19F2N3O5 | 2244161-72-4 | Details |
| Azilsartan Impurity 37 | C25H23N3O4 | 147404-76-0 | Details |
| (2β,3α,5α,16β,17β)-2,16-Di-(1-piperidinyl)androstane-3,17-diol 3-Acetate | C31H52N2O3 | 53357-31-6 | Details |
| Dolutegravir Impurity 10 | C20H20FN3O5 | 1863916-87-3 | Details |
| Acitretin Related Compound A (20 mg) ((2Z,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid) | C21H26O3 | 69427-46-9 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 | ||||